Synergistic anti-tumor effects of melatonin and PUFAs from walnuts in a murine mammary adenocarcinoma model

Nutrition

Volumn 31, Issue 4, 2015, Pages 570-577

  Garcia, Carolina P ^a   Lamarque, Alicia L ^b   Comba, Andrea ^a   Berra, María A ^a   Silva, Renata A ^a   Labuckas, Diana O ^b   Das, Undurti N ^c,d,e   Eynard, Aldo R ^a   Pasqualini, Maria E ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Instituto Multidisciplinario de Biologia Vegetal   (Argentina)

^c UND Life Sciences   (United States)

^d JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^e GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

Author keywords

Cancer; Diet; Eicosanoids; Phytomelatonin; PUFAs

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; CORN OIL; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; LINOLEIC ACID; LIPOXYGENASE; MELATONIN; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN SYNTHASE; ANTINEOPLASTIC AGENT; OMEGA 3 FATTY ACID; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER SURVIVAL; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; FLOUR; IMMUNE RESPONSE; LIPID COMPOSITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; WALNUT; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BREAST NEOPLASMS; CHEMISTRY; DIET; DISEASE MODEL; DRUG POTENTIATION; FEMALE; MALE; METABOLISM; NUT; PHYTOTHERAPY;

JUGLANS; MURINAE; MUS; ZEA MAYS;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DIET; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FATTY ACIDS, OMEGA-3; FEMALE; JUGLANS; LINOLEIC ACID; LIPOXYGENASE; MALE; MELATONIN; MICE, INBRED BALB C; NUTS; PHYTOTHERAPY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 84924787767     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.06.001     Document Type: Article

References (56)

1. Li Y., Chen H., Hardy T.M., Tolesfsbol T.O. Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein. PLoS One 2013, 8:e54369.
2. Vera-Ramirez L., Ramirez-Tortosa M.C., Sanchez-Rovira P., Tortosa C.L., Granados-Principal S., Lorente J.A., et al. Impact of diet on breast cancer risk: a review of experimental and observational studies. Crit Rev Food Sci Nutr 2013, 53:49-75.
3. Riediger N.D., Othman R.A., Suh M., Moghadasian M.H. Systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009, 109:668-679.
4. Comba A., Pasqualini M.E. Primers on molecular pathways-lipoxygenases: their role as an oncogenic pathway in pancreatic cancer. Pancreatology 2009, 9:724-728.
5. Moreno J.J. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem Pharmacol 2009, 77:1-10.
6. Stehle J.H., Saade A., Rawashdeh O., Ackermann K., Jilg A., Sebestény T., et al. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011, 51:17-43.
7. Okazaki M., Ezura H. Profiling of melatonin in the model tomato (Solanum lycopersicum L.) cultivar MicroTom. J Pineal Res 2009, 46:338-343.
8. Paredes S.D., Korkmaz A., Manchester L.C., Tan D.X., Reiter R.J. Phytomelatonin: review. J Exp Bot 2009, 60:57-69.
9. Tamura H., Takasaki A., Taketani T., Tanabe M., Kizuka F., Lee L., et al. The role of melatonin as an antioxidant in the follicle. J Ovarian Res 2012, 5:5.
10. Mandera M. Usefulness of melatonin in the diagnostics and therapy of pineal gland and brain neoplasms. Wiad Lek 2003, 56:569-573.
11. Grant S.G., Melan M.A., Latimer J.J., Witt-Enderby P.A. Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. Expert Rev Mol Med 2009, 11:e5.
12. Cardinali D.P., Esquifino A.I., Srinivasan V., Pandi-Perumal S.R. Melatonin and the immune system in aging. Neuroimmunomodulation 2008, 15:272-278.
13. Lardone P.J., Carrillo-Vico A., Molinero P., Rubio A., Guerrero J.M. A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: significance in IL-2 production. Cell Mol Life Sci 2009, 66:516-525.
14. Dubocovich M.L., Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005, 27:101-110.
15. Reiter R.J., Tan D.X., Manchester L.C., Pilar Terron M., Flores L.J., Koppisepi S. Medical implications of melatonin: Receptor-mediated and receptor-independent action. Adv Med Sci 2007, 52:11-18.
16. Dubocovich M.L., Delagrange P., Krause D.N., Cardinali D.P. International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. J Pharmacol Rev 2010, 62:343-380.
17. Radogna F., Sestili P., Martinelli C., Paolillo M., Paternoster L., Albertini M.C., et al. Lipoxygenase-mediated pro-radical effect of melatonin via stimulation of arachidonic acid metabolism. Toxicol Appl Pharmacol 2009, 238:170-177.
18. Zuo X., Shureiqi I. Eicosanoid profiling in colon cancer: emergence of a pattern. Prostaglandins Other Lipid Mediat 2013, 104-105:139-143.
19. Pasqualini M.E., Heyd V.L., Manzo P., Eynard A.R. Association between E-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE: 15-HETE ratio. A possible role of their metastatic potential. Prostagl Leukot Essent Fatty Acids 2003, 68:9-16.
20. Espada C.E., Berra M.A., Martinez M.J., Eynard A.R., Pasqualini M.E. Effect of chia oil (Salvia hispanica) rich in ω-3 fatty acids on the eicosanoid release, apoptosis and T-lymphocyte tumor infiltration in a murine mammary gland adenocarcinoma. Prostagl Leukot Essent Fatty Acids 2007, 77:21-28.
21. Martínez M.L., Labuckas D.O., Lamarque A.L., Maestri D.M. Walnut (Juglans regia L.) genetic resources, chemistry, by-products. J Sci Food Agric 2010, 90:1959-1967.
22. Tobares L., Guzmán C., Maestri D.M. Effect of the extraction and bleaching-processes on Jojoba (Simmondsia chinensis) wax quality. Eur J Lipid Sci Technol 2003, 105:749-753.
23. Pereyra-Alfonso S., Solarz G.R., Bal De KIer Joffé E. Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities. Clin Exp Metastasis 1992, 10:395-401.
24. Comba A., Maestri D.M., Berra M.A., Garcia C.P., Das U.N., Eynard A.R., et al. Effect of ω-3 and ω-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model. Lipids Health and Dis 2010, 9:112-119.
25. Maestri D.M., Guzmán C.A. A comparative study of seed lipid components of Nicotianeae (Solanaceae). Biochem Syst Ecol 1995, 23:201-207.
26. Kelavkar U.P., Hutzley J., Mc Hugh K., Allen K.G., Parwani A. Prostate tumour growth can be modulated by dietary targeting the 15-lipoxygenase- I and cyclooxygenase-2 enzymes. Neoplasia 2009, 11:692-699.
27. Calderón R.O., Eynard A.R. Fatty acids specifically related to the anisotropic properties of plasma membrane from rat urothelium. Biochim Biophys Acta 2000, 1483:174-184.
28. Pasqualini M.E., Mohn C.E., Petiti J.P., Manzo P., Eynard A.R. COX and LOX eicosanoids modulate platelet activation and procoagulation induced by two murine cancer cells. Prostagl Leuk Essent Fatty Acids 2000, 63:377-383.
29. Reiter R.J., Manchester L.C., Tan D.X. Melatonin in walnuts: influence on levels of melatonin and withtal antioxidant capacity of blood. Nutrition 2005, 21:920-924.
30. Muñoz J.L.P., Ceinos R.M., Soengas J.L., Míguez J.M. A simple and sensitive method for determination of melatonin in plasma, bile and intestinal tissue by high performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:2173-2177.
31. Vermmes C., Haanen C.P., Reutelingsperger M. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 1995, 180:38-52.
32. Maruoka H., Ikarashi Y., Shinohara K., Miyata M., Sugimura T., Terada M., et al. A novel monoclonal antibody permitting recognition of NKT cells in various mouse strains. Biochem Biophys Res Commun 1998, 242:413-418.
33. In- Kwon Y. Generalized weighted additive models based on distribution functions. Stat Probab Lett 2007, 77:1394-1402.
34. Padley F.B., Gunstone F.D., Harwood J.L. Occurrence and characteristics of oils and fats. The lipid landbook 1986, 49-170. Chapman and Hall, London, New York, Ed. F.D. Gunstone, J.L. Harwood, F.B. Padley (Eds.).
35. Blask D.E., Dauchy R.T., Sauer L.A., Krause J.A. Melatonin uptake and growth prevention in rat hepatoma 7288 CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. Carcinogenesis 2004, 25:951-960.
36. Anand P., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008, 25:2097-2116.
37. Das U.N. Essential fatty acids: biochemistry and physiology. Metabolic syndrome pathophysiology: the role of essential fatty acids 2010, 181-200. Wiley-Blackwell, Ames, IA. U.N. Das (Ed.).
38. Comba A., Yi-Hui L., Eynard A.R., Valentich M.A., Fernandez-Zapico M.E., Pasqualini M.E. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metast Rev 2011, 30:325-342.
39. He C., Qu X., Wan J., Rong R., Huang L., Cai C., et al. Inhibiting delta-6 desaturase activity suppresses tumor growth in mice. PLoS One 2012, 7:e47567.
40. Horrobin D.F., Ziboh V.A. The importance of linoleic acid metabolites in cancer metastasis and in the synthesis and actions of 13-HODE. Adv Exp Med Biol 1997, 433:291-294.
41. Hill S.M., Blask D.E., Xiang S., Yuan L., Mao L., Dauchy R.T., et al. Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia 2011, 16:235-245.
42. Dong Z., Liu Y., Scott K.F., Levin L., Gaitonde K., Bracken R.B., et al. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis 2010, 31:1948-1955.
43. Das U.N. Essential fatty acids: a review. Curr Pharm Biotechnol 2006, 7:467-482.
44. Blask D.E., Sauer L.A., Dauchy R.T., Holowachuk E.W., Ruhoff M.S., Kopff H.S. Melatonin inhibition of cancer growth invivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 1999, 59:4693-4701.
45. Blask D.E., Hill S.M., Dauchy R.T., Xiang S., Yuan L., Duplessis T., et al. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 2011, 51:259-269.
46. Martínez-Campa C., González A., Mediavilla M.D., Alonso-González C., Álvarez-García V., Sánchez-Barceló E.J., et al. Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br J Cancer 2009, 101:1613-1619.
47. Labuckas D.O., Maestri D.M., Perelló M., Martínez M.L., Lamarque A.L. Phenolics from walnut (Juglans regia l.) kernels: antioxidant activity and interactions with proteins. Food Chem 2008, 107:607-612.
48. Ding X.Z., Tong W.G., Adrian T.E. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res 2000, 20:2625-2631.
49. Oraldi M., Trombetta A., Biasi F., Canuto R.A., Maggiora M., Muzio G. Decreased polyunsaturated fatty acid content contributes-increased survival in human colon cancer. J Oncology 2009, 2009:867915.
50. Lissoni P. Modulation of anticancer cytokines IL-2 and IL-12 by melatonin and the other pineal indoles 5-methoxytryptamine and 5-methoxytryptophol in the treatment of human neoplasms. Ann N Y Acad Sci 2000, 917:560-782.
51. Miller S.C., Pandi-Perumal S.R., Esquifino A.I., Cardinali D.P., Maestroni G.J. The role of melatonin in immuno-enhancement: potential application in cancer. Int J Exp Pathol 2006, 87:81-87.
52. Maclennan M., Ma D.W. Role of dietary fatty acids in mammary gland development and breast cancer. Breast Cancer Res 2010, 12:211.
53. Eynard A.R., Navarro A. Crosstalk among dietary polyunsaturated fatty acids, urolithiasis, chronic inflammation, and urinary tract tumor risk. Nutrition 2013, 29:930-938.
54. Das U.N. Melatonin: is it an endogenous antimutagenic, oncostatic and antiageing molecule?. Med Sci Res 1994, 22:463-466.
55. Das U.N. Melatonin in the pathobiology and treatment of cancer. Cancer J 1995, 8:103-108.
56. Das U.N. Melatonin in human reproduction. Singapore J Obstet Gynecol 1996, 27:23-30.